Stayble Therapeutics Company
%20.jpg)
Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain triggered by degenerative changes in the disc. Stayble’s treatment has the potential to offer a solution that may alleviate or abolish the pain without the need for surgery Behind Stayble Therapeutics stands an experienced, multidisciplinary team including a world-renowned back-pain researcher, experienced bio-entrepreneurs and former big pharma senior management. Their vision is that this treatment concept will reach out to millions of patients who are disabled by chronic back pain. We believe this drug has the potential to drastically reduce the suffering from a widespread, incapacitating condition.
%20.jpg)
Founded Date:
2012-01-01
Last Funding Type:
Venture - Series Unknown
Headquarters:
Göteborg, Vastra Gotaland, Sweden
Investors Number:
1
Technology:
Others
Employee Number:
1-10
Industry:
Biotechnology, Health Care, Science and Engineering
Estimated Revenue:
$1M to $10M
Investor Type:
For Profit
Total Funding:
$6M